⌘K

Home/Filings/4/0001662252-19-000014

4//SEC Filing

Genkin Dmitry 4

Accession 0001662252-19-000014

CIK 0001534525other

View on SEC.gov Company Profile

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:30 PM ET

Size

4.8 KB

Accession

0001662252-19-000014

Insider Transaction Report

Form 4

Period: 2018-03-14

Xenetic Biosciences, Inc.XBIO

Director

Transactions

Other
Common Stock
2018-03-14−29,452→ 2,549 total

Footnotes (1)

[F1]On March 14, 2018, the Reporting Person transferred 29,452 shares to a third party as part of a settlement agreement dated October 18, 2017.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Xenetic Biosciences, Inc.

CIK 0001534525

Entity typeother

Related Parties

1

filerCIK 0001711592

Filing Metadata

Form type: 4
Filed: Jan 30, 7:00 PM ET
Accepted: Jan 31, 4:30 PM ET
Size: 4.8 KB

View on SEC.gov